Michael A. Metzger

Insider Reports History

Location
Waltham, MA
Signature
/s/ Michael A. Metzger
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael A. Metzger:

Company Role Class Num Shares Value Price $ Report Date Ownership
Syndax Pharmaceuticals Inc Chief Executive Officer, Director Common Stock 298,661 $4,902,191 $16.41 08 Sep 2025 Direct
Pyxis Oncology, Inc. Director Stock Option (Right to Buy) 36,979 $36,239 $0.9800 31 Mar 2025 Direct
Syndax Pharmaceuticals Inc Chief Executive Officer, Director Stock options (Right to buy) 0 $0 $14.65 08 Sep 2025 Direct
CTI BIOPHARMA CORP Director common stock 0 $9.10 08 Nov 2022 Direct
CTI BIOPHARMA CORP Director Stock Option (Right to Buy) 0 26 Jun 2023 Direct

Insider Reports Filed by Michael A. Metzger

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SNDX Syndax Pharmaceuticals Inc 08 Sep 2025 3 -$867,375 4 Chief Executive Officer, Director 08 Sep 2025, 18:45
SNDX Syndax Pharmaceuticals Inc 16 Jul 2025 1 -$69,953 4 Chief Executive Officer, Director 18 Jul 2025, 16:30
PYXS Pyxis Oncology, Inc. 31 Mar 2025 1 +$36,239 4 Director 02 Apr 2025, 09:05
SNDX Syndax Pharmaceuticals Inc 14 Mar 2025 2 +$43,733 4 Chief Executive Officer, Director 17 Mar 2025, 06:01
SNDX Syndax Pharmaceuticals Inc 04 Mar 2025 3 -$61,303 4 Chief Executive Officer, Director 06 Mar 2025, 16:10
SNDX Syndax Pharmaceuticals Inc 10 Feb 2025 1 -$206,017 4 Chief Executive Officer, Director 12 Feb 2025, 17:15
SNDX Syndax Pharmaceuticals Inc 05 Feb 2025 3 +$5,332,600 4 Chief Executive Officer, Director 07 Feb 2025, 16:42
PYXS Pyxis Oncology, Inc. 10 Jun 2024 1 $0 4 Director 10 Jun 2024, 17:31
PYXS Pyxis Oncology, Inc. 10 Jun 2024 0 $0 3 Director 10 Jun 2024, 17:26
SNDX Syndax Pharmaceuticals Inc 07 Feb 2024 3 +$4,779,060 4 Chief Executive Officer, Director 09 Feb 2024, 16:05
/report/000089924323016486-metzger-michael-a-2023-06-26 CTI BIOPHARMA CORP 26 Jun 2023 6 $0 4 Director 26 Jun 2023, 16:05
/report/000089924323010983-metzger-michael-a-2023-04-05 CTI BIOPHARMA CORP 05 Apr 2023 1 $0 4 Director 07 Apr 2023, 18:22
SNDX Syndax Pharmaceuticals Inc 06 Feb 2023 3 -$291,376 4 Chief Executive Officer, Director 08 Feb 2023, 15:49
SNDX Syndax Pharmaceuticals Inc 02 Feb 2023 1 +$11,705,500 4 Chief Executive Officer, Director 03 Feb 2023, 16:02
/report/000089129322000055-metzger-michael-a-2022-11-08 CTI BIOPHARMA CORP 08 Nov 2022 7 -$424,047 4 Director 10 Nov 2022, 15:54
SNDX Syndax Pharmaceuticals Inc 06 Oct 2022 3 -$268,162 4 Chief Executive Officer, Director 07 Oct 2022, 16:05
SNDX Syndax Pharmaceuticals Inc 30 Sep 2022 9 -$548,736 4 Chief Executive Officer, Director 04 Oct 2022, 17:49
SNDX Syndax Pharmaceuticals Inc 25 Jul 2022 6 -$463,772 4 Chief Executive Officer, Director 27 Jul 2022, 18:42
/report/000089129322000036-metzger-michael-a-2022-07-07 CTI BIOPHARMA CORP 07 Jul 2022 6 -$130,995 4 Director 11 Jul 2022, 16:51
SNDX Syndax Pharmaceuticals Inc 06 Jul 2022 6 -$222,012 4 Chief Executive Officer, Director 08 Jul 2022, 17:51
/report/000089129322000035-metzger-michael-a-2022-07-05 CTI BIOPHARMA CORP 05 Jul 2022 6 -$479,107 4 Director 07 Jul 2022, 17:02
/report/000089924322010776-metzger-michael-a-2022-03-09 CTI BIOPHARMA CORP 09 Mar 2022 1 $0 4 Director 11 Mar 2022, 18:43
SNDX Syndax Pharmaceuticals Inc 02 Feb 2022 1 +$5,131,750 4 Chief Executive Officer, Director 03 Feb 2022, 16:33
SNDX Syndax Pharmaceuticals Inc 16 Dec 2021 12 -$1,050,501 4 President and COO, Director 20 Dec 2021, 17:44
SNDX Syndax Pharmaceuticals Inc 13 Dec 2021 6 -$462,276 4 President and COO, Director 15 Dec 2021, 16:35
SNDX Syndax Pharmaceuticals Inc 25 Oct 2021 6 -$728,960 4 President and COO, Director 27 Oct 2021, 16:11
SNDX Syndax Pharmaceuticals Inc 27 Sep 2021 3 -$300,885 4 President and COO, Director 28 Sep 2021, 16:36
SNDX Syndax Pharmaceuticals Inc 20 Sep 2021 9 -$439,607 4 President and COO, Director 22 Sep 2021, 16:50
SNDX Syndax Pharmaceuticals Inc 13 Sep 2021 6 -$726,833 4 President and COO, Director 15 Sep 2021, 16:16